Ensysce Biosciences, Inc. (ENSC)

NASDAQ: ENSC · IEX Real-Time Price · USD

0.475

-0.018 (-3.59%)

At close: Jul 2, 2024, 3:57 PM

0.482

+0.007 (1.39%)

After-hours: Jul 2, 2024, 5:46 PM EDT

Ensysce Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2017
Net Income	-10.63	-25.09	-29.89	0.06	-10.1	Upgrade
Depreciation & Amortization	0	0	0	0	0	Upgrade
Share-Based Compensation	0.88	1.07	0.12	0.18	6.04	Upgrade
Other Operating Activities	-1.05	5.21	20.72	-1.48	3.13	Upgrade
Operating Cash Flow	-10.78	-17.89	-8.24	-1.25	-0.94	Upgrade
Capital Expenditures	0	0	0	0	0	Upgrade
Investing Cash Flow	0	0	0	0	0	Upgrade
Share Issuance / Repurchase	9.05	3.78	6.89	0	0	Upgrade
Debt Issued / Paid	0.15	5.53	13.42	1.1	0.5	Upgrade
Other Financing Activities	-0.45	-0.55	-	0	-	Upgrade
Financing Cash Flow	8.76	8.77	20.31	1.1	0.5	Upgrade
Net Cash Flow	-2.02	-9.12	12.07	-0.15	-0.44	Upgrade
Free Cash Flow	-10.78	-17.88	-8.24	-1.25	-0.94	Upgrade
Free Cash Flow Per Share	-4.76	-99.39	-98.10	-18.98	-9.02	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).